396 related articles for article (PubMed ID: 30374974)
1. The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms.
Xia Y; Cai XY; Fan JQ; Zhang LL; Ren JH; Li ZY; Zhang RG; Zhu F; Wu G
Int J Cancer; 2019 May; 144(9):2227-2238. PubMed ID: 30374974
[TBL] [Abstract][Full Text] [Related]
2. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
Xia Y; Cai X; Fan J; Zhang L; Li Z; Ren J; Wu G; Zhu F
Anticancer Drugs; 2017 Jun; 28(5):514-521. PubMed ID: 28225457
[TBL] [Abstract][Full Text] [Related]
3. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
4. Baicalein suppresses vasculogenic mimicry through inhibiting RhoA/ROCK expression in lung cancer A549 cell line.
Zhang Z; Nong L; Chen M; Gu X; Zhao W; Liu M; Cheng W
Acta Biochim Biophys Sin (Shanghai); 2020 Sep; 52(9):1007-1015. PubMed ID: 32672788
[TBL] [Abstract][Full Text] [Related]
5. Rho Kinase Inhibitor Fasudil Suppresses the Vasculogenic Mimicry of B16 Mouse Melanoma Cells Both In Vitro and In Vivo.
Xia Y; Cai XY; Fan JQ; Zhang LL; Ren JH; Chen J; Li ZY; Zhang RG; Zhu F; Wu G
Mol Cancer Ther; 2015 Jul; 14(7):1582-90. PubMed ID: 25934709
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the expression of ARHGAP25 and RhoA in non-small cell lung cancer and vasculogenic mimicry.
Shi F; Wu J; Jia Q; Li K; Li W; Shi Y; Wang Y; Wu S
BMC Pulm Med; 2022 Oct; 22(1):377. PubMed ID: 36207695
[TBL] [Abstract][Full Text] [Related]
7. CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A.
Xu N; Liu F; Wu S; Ye M; Ge H; Zhang M; Song Y; Tong L; Zhou J; Bai C
BMC Cancer; 2020 Mar; 20(1):262. PubMed ID: 32228507
[TBL] [Abstract][Full Text] [Related]
8. Plexin-B1 activates NF-κB and IL-8 to promote a pro-angiogenic response in endothelial cells.
Yang YH; Zhou H; Binmadi NO; Proia P; Basile JR
PLoS One; 2011; 6(10):e25826. PubMed ID: 22028792
[TBL] [Abstract][Full Text] [Related]
9. The Semaphorin 4D-Plexin-B1-RhoA signaling axis recruits pericytes and regulates vascular permeability through endothelial production of PDGF-B and ANGPTL4.
Zhou H; Yang YH; Basile JR
Angiogenesis; 2014 Jan; 17(1):261-74. PubMed ID: 24114199
[TBL] [Abstract][Full Text] [Related]
10. Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer.
Fan X; Huang J; Hu B; Zhou J; Chen L
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8729-8741. PubMed ID: 37129607
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer.
Kato S; Kubota K; Shimamura T; Shinohara Y; Kobayashi N; Watanabe S; Yoneda M; Inamori M; Nakamura F; Ishiguro H; Nakaigawa N; Nagashima Y; Taguri M; Kubota Y; Goshima Y; Morita S; Endo I; Maeda S; Nakajima A; Nakagama H
Cancer Sci; 2011 Nov; 102(11):2029-37. PubMed ID: 21812859
[TBL] [Abstract][Full Text] [Related]
12. Grb2 mediates semaphorin-4D-dependent RhoA inactivation.
Sun T; Krishnan R; Swiercz JM
J Cell Sci; 2012 Aug; 125(Pt 15):3557-67. PubMed ID: 22505611
[TBL] [Abstract][Full Text] [Related]
13. ROCK is involved in vasculogenic mimicry formation in hepatocellular carcinoma cell line.
Zhang JG; Li XY; Wang YZ; Zhang QD; Gu SY; Wu X; Zhu GH; Li Q; Liu GL
PLoS One; 2014; 9(9):e107661. PubMed ID: 25238232
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling.
Zhang JG; Zhou HM; Zhang X; Mu W; Hu JN; Liu GL; Li Q
BMC Cancer; 2020 Jan; 20(1):32. PubMed ID: 31931758
[TBL] [Abstract][Full Text] [Related]
15. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
16. VEGF and SEMA4D have synergistic effects on the promotion of angiogenesis in epithelial ovarian cancer.
Chen Y; Zhang L; Liu WX; Wang K
Cell Mol Biol Lett; 2018; 23():2. PubMed ID: 29308068
[TBL] [Abstract][Full Text] [Related]
17. Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis.
Basile JR; Castilho RM; Williams VP; Gutkind JS
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9017-22. PubMed ID: 16754882
[TBL] [Abstract][Full Text] [Related]
18. Semaphorin 4D induces vaginal epithelial cell apoptosis to control mouse postnatal vaginal tissue remodeling.
Ito T; Bai T; Tanaka T; Yoshida K; Ueyama T; Miyajima M; Negishi T; Kawasaki T; Takamatsu H; Kikutani H; Kumanogoh A; Yukawa K
Mol Med Rep; 2015 Feb; 11(2):829-36. PubMed ID: 25351707
[TBL] [Abstract][Full Text] [Related]
19. Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype.
Yao L; Zhang D; Zhao X; Sun B; Liu Y; Gu Q; Zhang Y; Zhao X; Che N; Zheng Y; Liu F; Wang Y; Meng J
J Cell Mol Med; 2016 Sep; 20(9):1673-85. PubMed ID: 27240974
[TBL] [Abstract][Full Text] [Related]
20. Sema4D/PlexinB1 promotes endothelial differentiation of dental pulp stem cells via activation of AKT and ERK1/2 signaling.
Zou T; Jiang S; Dissanayaka WL; Heng BC; Xu J; Gong T; Huang X; Zhang C
J Cell Biochem; 2019 Aug; 120(8):13614-13624. PubMed ID: 30937968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
